跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP CALCIUM POLYSTYRENE SULFONATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP CALCIUM POLYSTYRENE SULFONATE
Authorized
STANDARD
JAMP CALCIUM POLYSTYRENE SULFONATE
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f0d0f7dfc0e96e36
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
f0d0f7dfc0e96e36
Drug Approval Canada Name
JAMP CALCIUM POLYSTYRENE SULFONATE
Product Name
JAMP CALCIUM POLYSTYRENE SULFONATE
Status
Dormant
Status Date
2024-07-31
Original Market Date
2022-05-02
Din
02502631
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral , Rectal
Schedule
Ethical
Ahfs
40:18.18
Atc Original
V03AE01 POLYSTYRENE SULPHONATE
Atc Name
v 03 ae 01
Aig Number
0113563002
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
CALCIUM POLYSTYRENE SULFONATE
999 MG / G
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f0d0f7dfc0e96e36
Type
Standard
Back to Health Canada Approvals